Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge

NCT05418049 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Fragile X Syndrome

Interventions

DRUG: Baclofen
DRUG: Memantine
DRUG: Roflumilast
DRUG: Placebo

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]